MASLD is commonly associated with elevated levels of key proinflammatory cytokines, especially tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.